Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives

OSLO, Norway, Feb. 12, 2025 /PRNewswire/ -- For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 531.3, which is 3.8 per cent up from 2023. Adjusted EBITDA amounted...